治験レーダー

ベータ

治験レーダーAI 試験候補者または患者患者の介護者医療専門家バイオテックプロバイオテック投資家研究者その他
	場所 Local Institution に一致する糖尿病の治験(臨床試験)を表示しています。健康状態や治療法を理解し、近くの治験を探すお手伝いができます。

私たちの検索ツールは英語のみをサポートしています。他の言語で検索と議論するには、上の治験レーダーを使用するか、以下の疾患と場所のフィルターを選択してください。

キーワードで検索...

実施場所または場所で検索...

試験タイトル	状況
PPAR-COMBO With Sulfonylurea NCT00162175	完了
Phase III Insulin Add-On Asia Regional Program - ST NCT02096705	完了結果公開
PPAR - Combination With Metformin NCT00162240	完了
Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes NCT00106808	完了
Dose Ranging Study With LT, Monotherapy, PPAR NCT00240383	完了
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00121641	完了結果公開
A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease. NCT00162344	完了
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone NCT00121667	完了結果公開
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone NCT00095030	完了
A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus NCT00263276	完了
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015	完了結果公開
Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients NCT00778622	完了結果公開
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise NCT01095653	完了結果公開
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control NCT00246987	完了
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone NCT01095666	完了結果公開
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics NCT00240370	完了
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes NCT01864174	完了結果公開
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes NCT01111955	完了
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes NCT01046422	完了
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes NCT00035568	完了
Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance NCT00699790	完了
Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin NCT00757588	完了結果公開
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment NCT00663260	完了結果公開
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty NCT00162357	完了
A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects NCT00162305	完了
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas NCT00313313	完了結果公開
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes NCT00736879	完了結果公開
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone NCT00528879	完了結果公開
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes NCT01646320	完了結果公開
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes NCT01619059	完了結果公開
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes NCT00859898	完了結果公開
An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets NCT00643851	完了結果公開
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise NCT00528372	完了結果公開
Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes NCT00094991	完了
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker NCT01137474	完了結果公開
Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone NCT00683657	完了結果公開
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication NCT01195662	完了結果公開
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes NCT01606007	完了結果公開
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone NCT00295633	完了結果公開
Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus NCT00885378	完了結果公開
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00316082	完了結果公開
Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg NCT00918138	完了結果公開
Add-on to Thiazolidinedione (TZD) Failures NCT00683878	完了結果公開
Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) NCT00707590	中止
Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea NCT02090673	完了
Japanese Phase 1 Multiple Ascending Dose Study NCT01515202	完了
Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil NCT01365091	完了結果公開
Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects NCT00562250	完了
Phase I Multiple-Ascending Dose (Japan) (MAD) NCT00538174	完了
forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP) NCT01944618	中止

治験レーダー

相・段階

種類

試験の種類

年齢区分

性別

プラセボ

相・段階

種類

試験の種類

年齢区分

性別